Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells

European Journal of Immunology

Volumn 37, Issue 4, 2007, Pages 954-965

  Humrich, Jens Y ^a,e   Thumann, Peter ^a   Greiner, Sebastian ^a   Humrich, Jan H ^b   Averbeck, Marco ^c   Schwank, Christiane ^a   Kämpgen, Eckhart ^a   Schuler, Gerold ^a   Jenne, Lars ^a,d  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d Hautzentrum Sellspeicher   (Germany)

^e DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

Chemokines; Dendritic cell; IFN ; Modified virus Ankara; Poxvirus

Indexed keywords

ALPHA INTERFERON; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 3; STROMAL CELL DERIVED FACTOR 1;

ANTIGEN PRESENTING CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME DEFICIENCY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION; LYMPHOID ORGAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRUS STRAIN; CELL CULTURE; CELL MOTION; DRUG ANTAGONISM; EVALUATION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; RECEPTORS, CHEMOKINE; VACCINIA VIRUS;

EID: 34249652534     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636230     Document Type: Article

References (56)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767-811.
3. Randolph, G. J., Beaulieu, S., Lebecque, S., Steinman, R. M. and Muller, W. A., Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998. 282: 480-483.
4. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994. 179: 1109-1118.
5. Sozzani, S., Sallusto, F., Luini, W., Zhou, D., Piemonti, L., Allavena, P., Van Damme, J. et al., Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 1995. 155: 3292-3295.
6. Sozzani, S., Luini, W., Borsatti, A., Polentarutti, N., Zhou, D., Piemonti, L., D'Amico, G. et al., Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 1997 159: 1993-2000.
7. Dieu, M. C., Vanbervliet, B., Vicari, A., Bridon, J. M., Oldham, E., Ait-Yahia, S., Briere, F. et al., Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998. 188: 373-386.
8. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. J. Exp. Med. 1995. 182: 389-400.
9. Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I. and Lanzavecchia, A., Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 1999. 189: 821-829.
10. Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S. and Lanzavecchia, A., Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998. 28: 2760-2769.
11. Sallusto, F. and Lanzavecchia, A., Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 2000. 177: 134-140.
12. Sozzani, S., Allavena, P., D'Amico, G., Luini, W., Bianchi, G., Kataura, M., Imai, T. et al., Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunot. 1998. 161: 1083-1086.
13. Yanagihara, S., Komura, E., Nagafune, J., Watarai, H. and Yamaguchi, Y., EBll/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 1998. 161: 3096-3102.
14. Saeki, H., Moore, A. M., Brown, M. J. and Hwang, S. T., Cutting edge: Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 1999. 162: 2472-2475.
15. Kellermann, S. A., Hudak, S., Oldham, E. R., Liu, Y. J. and McEvoy, L. M., The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J. Immunol. 1999. 162: 3859-3864.
16. Cyster, J. G., Chemokines and cell migration in secondary lymphoid organs. Science 1999. 286: 2098-2102.
17. Fenner, F., A successful eradication campaign. Global eradication of smallpox. Rev. Infect. Dis. 1982. 4: 916-930.
18. Carroll, M. W. and Moss, B., Poxviruses as expression vectors. Curr. Opin. Biotechnol. 1997. 8: 573-577.
19. Humrich, J. and Jenne, L., Viral vectors for clendritic cell-based immunotherapy. Curr. Top. Microbiol. Immunol. 2003. 276: 241-259.
20. Banchereau, J., Schuler-Thurner, B., Palucka, A. K. and Schuler, G., Dendritic cells as vectors for therapy. Cell 2001. 106: 271-274.
21. Schuler, G., Schuler-Thurner, B. and Steinman, R. M., The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 2003. 15: 138-147.
22. Lane, J. M. and Goldstein, J., Evaluation of 21st-century risks of smallpox vaccination and policy options. Ann. Intern. Med. 2003. 138: 488-493.
23. Alcami, A. and Koszinowski, U. H., Viral mechanisms of immune evasion. Immunol. Today 2000. 21: 447-455.
24. Seet, B. T., Johnston, J. B., Brunetti, C. R., Barrett, J. W., Everett, H., Cameron, C., Sypula, J. et al., Poxviruses and immune evasion. Annu. Rev. Immunol. 2003. 21: 377-423.
25. Kotwal, G. J., Poxviral mimicry of complement and chemokine system components: What's the end game? Immunol. Today 2000. 21: 242-248.
26. Alcami, A., Symons, J. A., Collins, P. D., Williams, T. J. and Smith, G. L., Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 1998. 160: 624-633.
27. Alcami, A., Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 2003. 3: 36-50.
28. Larsson, M., Beignon, A. S. and Bhardwaj, N., DC-virus interplay: a double edged sword. Semin. Immunol. 2004. 16: 147-161.
29. Jenne, L., Schuler, G. and Steinkasserer, A., Viral vectors for dendritic cell-based immunotherapy. Trends Immunol. 2001. 22: 102-107.
30. Jenne, L., Hauser, C., Arrighi, J. F., Saurat, J. H. and Hugin, A. W., Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function. Gene Ther. 2000. 7: 1575-1583.
31. Engelmayer, J., Larsson, M., Subklewe, M., Chahroudi, A., Cox, W. I., Steinman, R. M. and Bhardwaj, N., Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 1999. 163: 6762-6768.
32. Drillien, R., Spehner, D., Bohbot, A. and Hanau, D., Vaccinia virus-related events and phenotypic changes after infection ofdendritic cells derived from human monocytes. Virology 2000. 268: 471-481.
33. Humrich, J. Y., Humrich, J. H., Averbeck, M., Thumann, P., Termeer, C., Kampgen, E., Schuler, G. and Jenne, L., Mature monocyte-derived dendritic cells respond more strongly to CCL19 than to CXCL12: consequences for directional migration. Immunology 2006. 117: 238-247.
34. Riol-Blanco, L., Sanchez-Sanchez, N., Torres, A., Tejedor, A., Narumiya, S., Corbi, A. L., Sanchez-Mateos, P. and Rodriguez-Fernandez, J. L., The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J. Immunol. 2005. 174: 4070-4080.
35. Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-dos-Santos, A. J., Stanford, W. L., Bolon, B., Wakeham, A. et al., Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000. 287: 1040-1046.
36. Li, Z., Jiang, H., Xie, W., Zhang, Z., Smrcka, A. V. and Wu, D., Roles of PLC-beta2 and-beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 2000. 287: 1046-1049.
37. Rossi, D. and Zlotnik, A., The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000. 18: 217-242.
38. Thelen, M., Dancing to the tune of chemokines. Nat. Immunol. 2001. 2: 129-134.
39. Rollins, B. J., Chemokines. Blood 1997. 90: 909-928.
40. Zella, D., Barabitskaja, O., Casareto, L., Romerio, F., Secchiero, P., Reitz, M. S. Jr., Gallo, R. C. and Weichold, F. F., Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells. J. Immunol. 1999. 163: 3169-3175.
41. Sallusto, F., Lenig, D., Mackay, C. R. and Lanzavecchia, A., Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 1998. 187: 875-883.
42. Drillien, R., Spehner, D. and Hanau, D., Modified vaccinia virus Ankara induces moderate activation of human dendritic cells. J. Gen. Virol. 2004. 85: 2167-2175.
43. Valderrama, F., Cordeiro, J. V., Schleich, S., Frischknecht, F. and Way, M., Vaccinia virus-induced cell motility requires F11L-mediated inhibition of RhoA signaling. Science 2006. 311: 377-381.
44. Blanchard, T. J., Alcami, A., Andrea, P. and Smith, G. L., Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J. Gen. Virol. 1998. 79: 1159-1167.
45. Antoine, G., Scheiflinger, F., Dorner, F. and Falkner, F. G., The complete genomic sequence of the modified vaccinia Ankara strain: comparison With other orthopoxviruses. Viroloy 1998. 244: 365-396.
46. Hirsch, E., Katanaev, V. L., Garlanda, C., Azzolino, O., Pirola, L., Silengo, L., Sozzani, S. et al., Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000. 287: 1049-1053.
47. Tilton, B., Ho, L., Oberlin, E., Loetscher, P., Baleux, F., Clark-Lewis, I. and Thelen, M., Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J. Exp. Med. 2000. 192: 313-324.
48. Jones, S. A., Moser, B. and Thelen, M., A comparison of post-receptor signal transduction events in Jurkat cells transfected with either IL-8R1 or IL-8P2. Chemokine mediated activation of p42/p44 MAP-kinase (ERK-2). FEBS Lett. 1995. 364: 211-214.
49. Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W. and Groopman, J. E., The alpha-chemokine, stromal cell-derived factor-1 alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J. Biol. Chem. 1998. 273: 23169-23175.
50. Knall, C., Worthen, G. S. and Johnson, G. L., Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc. Natl. Acad. Sci. USA 1997. 94: 3052-3057
51. Sanchez-Sanchez, N., Riol-Blanco, L., De La Rosa, G., Puig-Kroger, A., Garcia-Bordas, J., Martin, D., Longo, N. et al., Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 2004. 104: 619-625.
52. Sanchez-Sanchez, N., Riol-Blanco, L. and Rodriguez-Fernandez, J. L., The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J. Immunol. 2006. 176: 5153-5159.
53. Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L. et al., The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 2003. 197: 343-351.
54. Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K. and O'Neill, L. A., A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 2000. 97: 10162-10167.
55. Varani, S., Frascaroli, G., Homman-Loudiyi, M., Feld, S., Landini, M. P. and Soderberg-Naucler, C., Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J. Leukoc. Biol. 2005. 77: 219-228.
56. Sutter, G. and Moss, B., Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 1992. 89: 10847-10851.